Peroneal mononeuropathy in pediatric Hodgkin's disease

Area of Science:

• Neurology
• Pediatric Oncology
• Neurotoxicology

Background:

• Hodgkin's disease is a cancer of the lymphatic system.
• Chemotherapy regimens like COPP (cyclophosphamide, vincristine, prednisolone, and procarbazine) are standard treatments.
• Peroneal nerve palsy is a known neurological complication, but its occurrence in pediatric cancer patients is less understood.

Observation:

• A 12-year-old boy with Hodgkin's disease experienced recurrent left peroneal nerve palsy.
• The palsy coincided with vincristine administration within COPP chemotherapy cycles.
• The patient habitually played video games for extended periods with legs crossed.

Findings:

• This case suggests a potential link between habitual leg crossing and chemotherapy-induced peroneal mononeuropathy in pediatric patients.
• Vincristine, a component of the COPP regimen, is a known neurotoxin.
• The peroneal neuropathy resolved spontaneously within months, both clinically and electromyographically.

Implications:

• Highlights the importance of considering positional factors in chemotherapy-induced nerve damage in children.
• Suggests that patient-specific habits, like leg crossing, may exacerbate neurotoxicity.
• Underscores the need for further research into the multifactorial causes of neuropathy in pediatric cancer survivors.